Tech Tuesday: New Senotherapeutic Agents for Cancer Therapy

We're back with another round of Innovation Institute's Tech Tuesdays, where we showcase the most cutting-edge technologies from our impressive portfolio of impactful innovations ready for licensing or strategic partnering! This week we feature a groundbreaking technique that may help improve the health of people dealing with prostate issues. The technology is led by Youko Ikeda, Anthony J. Kanai, and Irina V. Zabbarova, who are all part of the Department of Medicine.

PopSole Puts Best Foot Forward

Pitt Duo Launches Innovative Shoe Insert to Help People With Foot Pain Beth and Jeff Gusenoff are a podiatrist and a plastic surgeon by trade, but entrepreneurs at heart. Over the past five years they have been developing a supportive pressure-reducing shoe insert crafted initially for their patients recovering from procedures that transfer fat to the bottom of the foot for various foot conditions. Now they have formally launched their company, PopSole™, hired a contract manufacturer in Western Pennsylvania and are pounding the pavement to find distribution partners.

Pitt Innovators Named Senior Member of National Academy of Inventors

The National Academy of Inventors (NAI) has selected three University of Pittsburgh professors among 83 academic inventors for the 2022 class of NAI Senior Members. They are: Antonio D’Amore, Research Assistant Professor, Surgery and Bioengineering and the McGowan Institute for Regenerative Medicine Cecelia Yates, Associate Professor, Health Promotion & Development, School of Nursing Maliha Zahid, Assistant Professor, Developmental Biology NAI Senior Members are active faculty, scientists and administrators from NAI member institutions who have demonstrated remarkable innovation-producing technologies that have brought, or aspire to bring, real impact on the welfare of society. They also have growing success in patents, licensing and commercialization.

Calming the Cytokine Storm

When Samira Kiani’s father was diagnosed with pancreatic cancer she scoured available clinical trials for cutting edge gene and cell therapies, but came away frustrated at the limitations posed by many of them as a result of their vulnerability to the body’s natural immune response to the therapies.

Should I Spin Out a Life Science Startup From My Academic Lab?

Innovation Institute Entrepreneur in Residence Michael Hufford recently signed on as CEO of Pitt Spinout LyGenesis Inc. In this blog post he takes a tongue-in-cheek approach to give advice to investigators who are considering whether to leave academia to join a startup built around their discoveries.

RECENT POSTS

SUBSCRIBE TO OUR BLOG